Pulmonary Arterial Hypertension (PAH)
Also known as: Hypertension, Pulmonary Artery / Pulmonary Arterial Hypertension / Hypertension, Pulmonary Arterial / Pulmonary Arterial Hypertension (CHD) / PAH / Pulmonary hypertensive arterial disease (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01240 | Epoprostenol | A vasodilator and platelet aggregation inhibitor used for the management of primary pulmonary hypertension and pulmonary hypertension in patients with heart failure. |
| DB08931 | Riociguat | A stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. |
| DB00203 | Sildenafil | A phosphodiesterase inhibitor used for the treatment of erectile dysfunction. |
| DB00820 | Tadalafil | A phosphodiesterase 5 inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. |
| DB00374 | Treprostinil | A prostacyclin vasodilator for the treatment of pulmonary arterial hypertension to relieve exercise associated symptoms and to prevent clinical deterioration after stopping epoprostenol. |